Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000174 per share
-
Shares outstanding
-
55,803,824
-
Total 13F shares
-
2,827,742
-
Share change
-
-353,285
-
Total reported value
-
$1,555,037
-
Price per share
-
$0.55
-
Number of holders
-
13
-
Value change
-
-$242,900
-
Number of buys
-
2
-
Number of sells
-
6
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q1 2025
As of 31 Mar 2025,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,827,742 shares.
The largest 10 holders included
BML Capital Management, LLC, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), CHOREO, LLC, RENAISSANCE TECHNOLOGIES LLC, Callan Capital, LLC, ROYAL BANK OF CANADA, GEODE CAPITAL MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, ADAR1 Capital Management, LLC, and UBS Group AG.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.